Crescent Discovery Series

A reading room for breakthroughs and the curious mind

Editing single DNA letters erased a teenager's leukemia

A 13-year-old girl's leukemia had come back after every standard treatment had failed.

The Crescent Team21 July, 4:35 PMChiesa et al., New England Journal of Medicine, 2023 · Great Ormond Street Hospital / UCL2 min read

Doctors at Great Ormond Street Hospital in London turned to an experimental therapy never used in a person before: donor immune cells with their DNA edited letter by letter so they would attack the cancer without attacking each other.

Researchers used base editing to change four genes in donor T cells, stripping markers that would let the cells be rejected or kill each other, then infused the engineered CAR7 cells into the girl in December 2022. Within a month her bone marrow showed no detectable leukemia.

A bone marrow transplant followed soon after to consolidate the remission, since the edited cells were not expected to last in her body indefinitely. She remained free of leukemia in follow-up reporting, but she is the only patient treated this way so far, and doctors are watching to see whether the approach works as well in others before calling it a cure.

Crescent Discovery Series cover: Editing single DNA letters erased a teenager's leukemia

One patient, four edited genes, one remission.

Source

  1. Chiesa, R., Georgiadis, C., Syed, F., Zhan, H., Etuk, A., Gkazi, S. A., Preece, R., Ottaviano, G., Braybrook, T., Chu, J., Kubat, A., Adams, S., Thomas, R., Gilmour, K., O’Connor, D., Vora, A., & Qasim, W. (2023). Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia. New England Journal of Medicine, 389(10), 899–910. https://doi.org/10.1056/NEJMoa2300709
Crescent Discovery Series

Follow the series

New discoveries are published on our channels every day.

Keep going

Three more numbers